THC
21%
CBD
0.5%
Ectoplasma, from Mephisto Genetics, is a hybrid strain with THC testing as high as 21 percent.
No effect, terpene, flavor or medical-use data specific to Ectoplasma has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
21% THC
About Ectoplasma
Mephisto Genetics' Ectoplasma is documented almost entirely by its potency: a hybrid with THC testing up to 21 percent, a solidly strong number by most standards. No lineage, flowering time, yield, effects, flavors, or medical applications have been published for this cut, which is fairly common for some of Mephisto's more limited or experimental releases. The ghostly name hints at genetics that might trace back to something with a similarly spectral theme, but nothing beyond the THC figure has made it into the public record for this particular version. For now, growers and buyers have a single reliable data point to go on, and it places Ectoplasma comfortably above average in strength even without a fuller picture of how it grows or smokes.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Ectoplasma
Is Ectoplasma an Indica, Sativa, or Hybrid?
Ectoplasma is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Ectoplasma?
Ectoplasma: 21% THC and 0.5% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.